republic-os/legislation/us/states/de/149/sb-45.md

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags

type	title	description	jurisdiction	legislature	session	identifier	citation	classification	subjects	status	primary_sponsors	version_count	action_count	vote_count	first_action	last_action	source	source_identifier	source_url	source_hash	vintage	source_snapshot	retrieved_at	confidence	tags
Bill	AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO THE UNIFORM CONTROLLED SUBSTANCES ACT.	This Bill adds 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide (U-47700) to Schedule I of the Uniform Controlled Substances Act. U-47700, also known as “Pink,” is a synthetic opioid recently encountered by law enforcement and public health officials and is being abused for its opioid properties. It is available over the Internet and is marketed as a “research chemical.” The safety risks to users are significant and the public health risks include large numbers of drug treatment admissions, emergency room visits and fatal overdoses. On November 14, 2016, the Federal Drug Enforcement Agency temporarily placed U-47700 in Schedule I for a two-year period, finding that this synthetic opioid has a high potential for abuse, no currently accepted medical use in treatment in the United States and lacks accepted safety for use under medical supervision. By Emergency Order dated December 15, 2016, the Secretary of State temporarily placed U-47700 in Schedule I. This Order is effective for 120 days. The permanent addition of U-47700 to Schedule I is required in the interest of public protection.	us/states/de	Delaware General Assembly	149	SB 45	Delaware SB 45 (149)	bill		enacted	Bryan Townsend David Bentz	1	8	2	2017-03-30	2017-07-17	openstates	ocd-bill/69e7fc5f-11d3-4f07-90ff-ff6632a21bd2	https://legis.delaware.gov/BillDetail?LegislationId=25565	155625ce6002fce5a1b70dd3b3a9009aa7aa86acb609f857a7ed06e6763bac1c	2026-07-01	https://data.openstates.org/daily/2026-07-01/public.pgdump	2026-07-06	reported	legislation bill us-de

Delaware SB 45 (149) — AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO THE UNIFORM CONTROLLED SUBSTANCES ACT.

This Bill adds 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide (U-47700) to Schedule I of the Uniform Controlled Substances Act. U-47700, also known as “Pink,” is a synthetic opioid recently encountered by law enforcement and public health officials and is being abused for its opioid properties. It is available over the Internet and is marketed as a “research chemical.” The safety risks to users are significant and the public health risks include large numbers of drug treatment admissions, emergency room visits and fatal overdoses. On November 14, 2016, the Federal Drug Enforcement Agency temporarily placed U-47700 in Schedule I for a two-year period, finding that this synthetic opioid has a high potential for abuse, no currently accepted medical use in treatment in the United States and lacks accepted safety for use under medical supervision. By Emergency Order dated December 15, 2016, the Secretary of State temporarily placed U-47700 in Schedule I. This Order is effective for 120 days. The permanent addition of U-47700 to Schedule I is required in the interest of public protection.

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

1. Bill Text (committee substitute) — source

Votes

• SM — 20–0 (pass) · upper
• SM — 40–0 (pass) · lower

Sponsors

• Bryan Townsend — primary (person)
• David Bentz — primary (person)
• Deborah Hudson — cosponsor (person)
• Debra Heffernan — cosponsor (person)
• Ernesto B Lopez — cosponsor (person)
• Gerald W. Hocker — cosponsor (person)
• Helene M. Keeley — cosponsor (person)
• Joseph E. Miro — cosponsor (person)
• Kimberly Williams — cosponsor (person)
• Ruth Briggs King — cosponsor (person)
• Stephanie L. Hansen — cosponsor (person)
• Trey Charles Paradee — cosponsor (person)

Timeline

The legislative action history — every referral, reading, and vote.

• 2017-03-30 Introduced and Assigned to Health, Children & Social Services Committee in Senate introduction, referral-committee
• 2017-04-05 Reported Out of Committee (Health, Children & Social Services) in Senate with 3 On Its Merits committee-passage
• 2017-04-26 Passed By Senate. Votes: 20 YES 1 ABSENT passage
• 2017-04-26 Passed By Senate. Votes: 20 YES 1 ABSENT passage
• 2017-04-27 Assigned to Health & Human Development Committee in House introduction, referral-committee
• 2017-05-03 Reported Out of Committee (Health & Human Development) in House with 9 On Its Merits committee-passage
• 2017-05-18 Passed By House. Votes: 40 YES 1 ABSENT passage
• 2017-07-17 Signed by Governor executive-signature

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/69e7fc5f-11d3-4f07-90ff-ff6632a21bd2. Confidence: reported (aggregated from official Delaware legislature records).